
Ticagreate 90mg Tablet
Marketer
Prevego Healthcare & Research Private Limited
Salt Composition
Ticagrelor (90mg)
Overview Ticagreate 90mg Tablet
Cardiogard 90mg tablets are antiplatelet agents, working to inhibit the creation of dangerous blood clots within blood vessels. This action helps prevent strokes and heart attacks in individuals with pre-existing heart conditions. Cardiogard 90mg is also indicated for patients recovering from a recent heart attack or experiencing unstable angina, particularly those who have received coronary stents. Its use minimizes the risk of subsequent cardiac events, including further heart attacks, strokes, and stent thrombosis. Concurrently, your physician will likely prescribe aspirin, another antiplatelet medication. Cardiogard 90mg may be ingested with or without food, consistently at the same time daily. Continued use is crucial, even in the absence of symptoms, as discontinuation increases the risk of recurrent cardiovascular events. The most frequent adverse effect is increased bleeding tendency; minor injuries may bleed longer than expected. Though usually self-limiting, prolonged or excessive bleeding should be reported. Some patients experience mild dyspnea, which generally subsides with ongoing treatment; persistent or worsening shortness of breath warrants medical attention. Cardiogard 90mg is contraindicated in patients with active internal bleeding (e.g., ulcers, intracranial hemorrhage) or liver disease. Disclose any such conditions to your doctor before commencing treatment.
Uses of Ticagreate 90mg Tablet
Reducing the risk of cardiac arrest and cerebrovascular events
Major Benefits of Ticagreate 90mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 90mg Ticagrelate tablet whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistency in timing is recommended.
Common Side effects of Ticagreate 90mg Tablet:
- Bleeding
- Breathlessness
How to use Ticagreate 90mg Tablet:
Your physician will determine the correct dosage and treatment length for this medication. Ingest the 90mg Ticagreate tablet whole; do not crush, chew, or divide it. While it can be taken with or without food, consistency is key—take it at the same time each day.
How Ticagreate 90mg Tablet works:
Brilinta 90mg tablets are antiplatelet agents. Their action inhibits platelet aggregation, reducing the risk of dangerous blood clot development. This, in turn, diminishes the likelihood of a stroke or heart attack.
SAFETY ADVICE
AlcoholCAUTION
Combining alcohol and Ticagrelor 90mg tablets requires careful consideration. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Ticagrelor 90mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of 90mg Ticagrelor tablets with breastfeeding are currently unavailable. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticagrelor 90mg tablets.
KidneySAFE IF PRESCRIBED
Ticagrelor 90mg tablets can be used safely in individuals with kidney impairment; no dosage modification is needed. Data regarding ticagrelor 90mg tablet use in patients undergoing renal dialysis is currently limited.
LiverCAUTION
Patients with liver impairment should use Ticagreate 90mg tablets cautiously, potentially requiring dosage modification. Severe hepatic disease contraindicates the use of Ticagreate 90mg tablets; physician consultation is advised.
What if you forget to take Ticagreate 90mg Tablet :
Should you forget a Ticagrelor 90mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ticagreate 90mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Action Class | ADP receptor antagonists (P2Y12 inhibitors) |
